Items where authors include "Ford, A.C."

Article

Black, C.J. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2025) The case for reducing the use of diagnostic upper and lower gastrointestinal endoscopy. The Lancet Gastroenterology & Hepatology, 10 (4). pp. 285-287. ISSN 2468-1253

Wright-Hughes, A. orcid.org/0000-0001-8839-6756, Ow, P.-L., Alderson, S.L. et al. (11 more authors) (2025) Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial. Gut. ISSN 0017-5749

Ford, A.C. orcid.org/0000-0001-6371-4359, Yuan, Y., Park, J.Y. et al. (2 more authors) (2025) Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive individuals: Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies. Gastroenterology. ISSN 0016-5085 (In Press)

Whelan, K., Ford, A.C. orcid.org/0000-0001-6371-4359, Burton-Murray, H. et al. (1 more author) (2024) Dietary management of irritable bowel syndrome: considerations, challenges, and solutions. The Lancet Gastroenterology & Hepatology, 9 (12). pp. 1147-1161. ISSN 2468-1253

Black, C.J. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2024) Personalisation of therapy in irritable bowel syndrome: a hypothesis. The Lancet Gastroenterology & Hepatology, 9 (12). pp. 1162-1176. ISSN 2468-1253

Din, S., Segal, J., Blackwell, J. et al. (3 more authors) (2024) Harms with placebo in trials of biological therapies and small molecules as induction therapy in inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 9 (11). p1020-p1029. ISSN 2468-1156

Riggott, C., Ford, A.C. orcid.org/0000-0001-6371-4359 and Gracie, D.J. (2024) Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications. Alimentary Pharmacology and Therapeutics, 60 (9). pp. 1200-1214. ISSN 0269-2813

Goodoory, V.C., Riggott, C., Khasawneh, M. et al. (2 more authors) (2024) Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Alimentary Pharmacology and Therapeutics. ISSN 0269-2813

Goodoory, V.C., Khasawneh, M., Thakur, E.R. et al. (9 more authors) (2024) Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis. Gastroenterology, 167 (5). p934-943.e5. ISSN 0016-5085

Wright-Hughes, A. orcid.org/0000-0001-8839-6756, Ford, A.C. orcid.org/0000-0001-6371-4359, Alderson, S.L. orcid.org/0000-0002-5418-0495 et al. (19 more authors) (2024) Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT. Health Technology Assessment, 28 (66). ISSN 1366-5278

Gros, B., Blackwell, J., Segal, J. et al. (3 more authors) (2024) Harms with placebo in trials of biological therapies and small molecules as maintenance therapy in inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 9 (11). pp. 1030-1040. ISSN 2468-1156

Thakur, E.R., Shapiro, J.M., Wellington, J. et al. (5 more authors) (2024) A systematic review of yoga for the treatment of gastrointestinal disorders. Neurogastroenterology & Motility. e14915. ISSN 1350-1925

Goodoory, V.C., Khasawneh, M., Black, C.J. et al. (1 more author) (2024) Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology, 22 (9). pp. 1942-1943. ISSN 1542-3565

Nardone, O.M., Calabrese, G., Bertin, L. et al. (5 more authors) (2024) Prevalence of Sexual Dysfunction in Inflammatory Bowel Disease: Systematic Review and Meta-analysis. Journal of Crohn's and Colitis. jjae133. ISSN 1197-4982

Porcari, S., Ingrosso, M.R., Maida, M. et al. (6 more authors) (2024) Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut, 73 (9). pp. 1431-1440. ISSN 0017-5749

Khasawneh, M., Black, C.J. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2024) Efficacy of Drugs Acting on Histamine 1 Receptors in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. Gastroenterology, 167 (2). 400-401.e3. ISSN 0016-5085

Black, C.J., Houghton, L.A. orcid.org/0000-0002-5351-0229, West, R.M. orcid.org/0000-0001-7305-3654 et al. (4 more authors) (2024) Novel Irritable Bowel Syndrome Subgroups are Reproducible in the Global Adult Population. Clinical Gastroenterology and Hepatology. ISSN 1542-3565

Ford, A.C. orcid.org/0000-0001-6371-4359, Staudacher, H.M. and Talley, N.J. (2024) Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target. Gut, 73 (7). pp. 1199-1211. ISSN 0017-5749

Ford, A.C. orcid.org/0000-0001-6371-4359, Vanner, S., Kashyap, P.C. et al. (1 more author) (2024) Chronic Visceral Pain: New Peripheral Mechanistic Insights and Resulting Treatments. Gastroenterology, 166 (6). pp. 976-994. ISSN 0016-5085

Khasawneh, M., Shaikh, F.A., Ng, C.E. et al. (3 more authors) (2024) Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden. Neurogastroenterology & Motility. e14756. ISSN 1350-1925

Barberio, B., Fairbrass, K.M. orcid.org/0000-0002-5569-4762, Gracie, D.J. et al. (1 more author) (2024) Natural history and impact of irritable bowel syndrome‐type symptoms in inflammatory bowel disease during 12 months of longitudinal follow‐up. Neurogastroenterology & Motility, 36 (2). e14713. ISSN 1350-1925

Goodoory, V.C. orcid.org/0000-0001-9483-5604, Tuteja, A.K., Black, C.J. et al. (1 more author) (2024) Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology, 22 (2). E5. pp. 243-251. ISSN 1542-3565

Barberio, B., Gracie, D.J., Black, C.J. et al. (1 more author) (2024) Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysis. Digestive and Liver Disease, 56 (1). pp. 7-14. ISSN 1590-8658

Khasawneh, M., Craig, O.F., Gracie, D.J. et al. (2 more authors) (2023) A Diagnosis of Irritable Bowel Syndrome Using Rome IV Criteria and Limited Investigations is Durable in Secondary Care. Clinical Gastroenterology and Hepatology, 21 (13). pp. 3397-3404. ISSN 1542-3565

Goodoory, V.C., Khasawneh, M., Black, C.J. et al. (3 more authors) (2023) Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology, 165 (5). pp. 1206-1218. ISSN 0016-5085

Riggott, C., Fairbrass, K.M., Selinger, C.P. et al. (2 more authors) (2023) Impact of Opioid Use on the Natural History of Inflammatory Bowel Disease: Prospective Longitudinal Follow-up Study. Inflammatory Bowel Diseases. ISSN 1078-0998

Ford, A.C., Wright-Hughes, A., Alderson, S.L. et al. (65 more authors) (2023) Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. ISSN 0140-6736

Visaggi, P. orcid.org/0000-0002-6985-5301, Barberio, B., Del Corso, G. et al. (4 more authors) (2023) Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis. Gut, 72 (11). pp. 2019-2030. ISSN 0017-5749

Riggott, C. orcid.org/0000-0002-6927-9498, Fairbrass, K.M. orcid.org/0000-0002-5569-4762, Black, C.J. orcid.org/0000-0001-5449-3603 et al. (2 more authors) (2023) Novel symptom clusters predict disease impact and healthcare utilisation in inflammatory bowel disease: Prospective longitudinal follow-up study. Alimentary Pharmacology & Therapeutics. ISSN 0269-2813

Riggott, C., Mikocka-Walus, A., Gracie, D.J. et al. (1 more author) (2023) Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 8 (10). pp. 919-931. ISSN 2468-1253

Chuah, K. orcid.org/0000-0001-9811-7546, Black, C.J. orcid.org/0000-0001-5449-3603, Tee, V. orcid.org/0000-0002-6562-2666 et al. (6 more authors) (2023) A prospective comparison of UK and Malaysian patients with irritable bowel syndrome in secondary care. Alimentary Pharmacology and Therapeutics, 58 (2). pp. 168-174. ISSN 0269-2813

Jaafari, H., Houghton, L.A. orcid.org/0000-0002-5351-0229, West, R.M. et al. (13 more authors) (2023) The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: results from the Rome foundation global epidemiology study. Neurogastroenterology & Motility, 35 (6). e14574. ISSN 1365-2982

Goodoory, V.C. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2023) Antibiotics and Probiotics for Irritable Bowel Syndrome. Drugs, 83 (8). pp. 687-699. ISSN 0012-6667

Hawkey, C., Avery, A., Coupland, C.A.C. et al. (25 more authors) (2022) Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial. The Lancet, 400 (10363). pp. 1597-1606. ISSN 0140-6736

Black, C.J., Paine, P.A., Agrawal, A. et al. (10 more authors) (2022) British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut, 71 (9). pp. 1697-1723. ISSN 0017-5749

Rej, A., Avery, A., Ford, A.C. et al. (8 more authors) (2018) Clinical application of dietary therapies in Irritable Bowel Syndrome. Journal of Gastrointestinal and Liver Diseases, 27 (3). pp. 307-316. ISSN 1841-8724